Skip to main content

Together we are beating cancer

Donate now

Search Results: immunotherapy

Showing 12 out of 584 results

Rising womb cancer rates, gene editing tech could help make immune cells better, missed waiting time targets and do ‘good’ bacteria make a difference? Rising womb cancer rates, gene editing tech could help make immune cells better, missed waiting time targets and do ‘good’ bacteria make a difference?

by Nick Peel | Analysis | 16 April 2016

16 April 2016

T cell

We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells. We explore how the latest gene editing technology could help our scientists engineer immune cells to precisely target and kill cancer cells.

by Alan Worsley | Analysis | 15 April 2016

15 April 2016

Cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy the disease. Cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy the disease.

by Cancer Research UK | News | 15 April 2016

15 April 2016

We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples. We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.

by Nick Peel | Analysis | 15 March 2016

15 March 2016

Human T cell.

Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system. Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system.

by In collaboration with PA Media Group | News | 11 March 2016

11 March 2016

Cancer Research UK logo

Scientists have made a groundbreaking discovery in understanding how the genetic complexity of tumours can be recognised and exploited by the immune system. Scientists have made a groundbreaking discovery in understanding how the genetic complexity of tumours can be recognised and exploited by the immune system.

by Cancer Research UK | News | 3 March 2016

3 March 2016